These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18554316)

  • 1. Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics.
    Barba I; Fernandez-Montesinos R; Garcia-Dorado D; Pozo D
    J Cell Mol Med; 2008; 12(5A):1477-85. PubMed ID: 18554316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation biomarker discovery in Alzheimer's disease using metabolomics - from animal to human studies.
    Hurtado MO; Kohler I; de Lange EC
    Bioanalysis; 2018 Sep; 10(18):1525-1546. PubMed ID: 30198770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the application of metabolomics to Alzheimer's Disease.
    Trushina E; Mielke MM
    Biochim Biophys Acta; 2014 Aug; 1842(8):1232-9. PubMed ID: 23816564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics: a new era in cardiology?
    Mercuro G; Bassareo PP; Deidda M; Cadeddu C; Barberini L; Atzori L
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):800-5. PubMed ID: 21934525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.
    Yilmaz A; Geddes T; Han B; Bahado-Singh RO; Wilson GD; Imam K; Maddens M; Graham SF
    J Alzheimers Dis; 2017; 58(2):355-359. PubMed ID: 28453477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
    J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid.
    Enche Ady CNA; Lim SM; Teh LK; Salleh MZ; Chin AV; Tan MP; Poi PJH; Kamaruzzaman SB; Abdul Majeed AB; Ramasamy K
    J Neurosci Res; 2017 Oct; 95(10):2005-2024. PubMed ID: 28301062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics-based promising candidate biomarkers and pathways in Alzheimer's disease.
    Kang J; Lu J; Zhang X
    Pharmazie; 2015 May; 70(5):277-82. PubMed ID: 26062293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of Metabolomic Measurement for Insights in Alzheimer's Disease Progression-What Is Missing?
    Yin C; Harms AC; Hankemeier T; Kindt A; de Lange ECM
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative metabolomics science in Alzheimer's disease: Relevance and future perspectives.
    Lista S; González-Domínguez R; López-Ortiz S; González-Domínguez Á; Menéndez H; Martín-Hernández J; Lucia A; Emanuele E; Centonze D; Imbimbo BP; Triaca V; Lionetto L; Simmaco M; Cuperlovic-Culf M; Mill J; Li L; Mapstone M; Santos-Lozano A; Nisticò R
    Ageing Res Rev; 2023 Aug; 89():101987. PubMed ID: 37343679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics in Alzheimer's disease: The need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology.
    González-Domínguez R; Sayago A; Fernández-Recamales Á
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1071():75-92. PubMed ID: 28189423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease.
    Xu XH; Huang Y; Wang G; Chen SD
    Neurosci Bull; 2012 Oct; 28(5):641-8. PubMed ID: 23054640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in Sporadic and Familial Alzheimer's Disease.
    Lista S; O'Bryant SE; Blennow K; Dubois B; Hugon J; Zetterberg H; Hampel H
    J Alzheimers Dis; 2015; 47(2):291-317. PubMed ID: 26401553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic Signatures of Alzheimer's Disease Indicate Brain Region-Specific Neurodegenerative Progression.
    Ambeskovic M; Hopkins G; Hoover T; Joseph JT; Montina T; Metz GAS
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Metabolomics in Alzheimer's Disease: Technical Considerations for Improved Reproducibility.
    Veiga S; Wahrheit J; Rodríguez-Martín A; Sonntag D
    Methods Mol Biol; 2018; 1779():463-470. PubMed ID: 29886550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic phenotyping of urine for discriminating alcohol-dependent from social drinkers and alcohol-naive subjects.
    Mostafa H; Amin AM; Teh CH; Murugaiyah V; Arif NH; Ibrahim B
    Drug Alcohol Depend; 2016 Dec; 169():80-84. PubMed ID: 27788404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis.
    Inoue K; Tsuchiya H; Takayama T; Akatsu H; Hashizume Y; Yamamoto T; Matsukawa N; Toyo'oka T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():24-34. PubMed ID: 25463194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking the potential involvement of metabolic disease in Alzheimer's disease-Biomarkers and beyond.
    Luchsinger JA; Zetterberg H
    Int Rev Neurobiol; 2020; 154():51-77. PubMed ID: 32739014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics toward personalized medicine.
    Jacob M; Lopata AL; Dasouki M; Abdel Rahman AM
    Mass Spectrom Rev; 2019 May; 38(3):221-238. PubMed ID: 29073341
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.